Keith S Heller

Biosketch / Results /

Keith Heller

Professor, Department of Surgery
NYU Endocrine Surgery Associates

Contact Info

Address
530 First Avenue
New York, NY 10016

Keith.Heller@nyumc.org


Education

1967-1971 — New York University School of Medicine, Medical Education
1971 — NYU School of Medicine, Medical Education
1971 — New York University, Medical Education
1971-1972 — General Surgery at New York University, Internship
1971-1976 — NYU School of Medicine, Residency Training
1971-1976 — NYU School of Medicine, Internship
1972-1976 — General Surgery at New York University, Residency Training
1976-1978 — Memorial Sloan-Kettering Cancer Center, Clinical Fellowships
1976-1978 — Memorial Sloan Kettering, Clinical Fellowships

Method of Detection of Well-Differentiated Thyroid Cancers in Obese and Non-Obese Patients
Zagzag, Jonathan; Malone, Michael K; Lopresti, Melissa A; Ogilvie, Jennifer B; Patel, Kepal N; Heller, Keith S. Method of Detection of Well-Differentiated Thyroid Cancers in Obese and Non-Obese Patients. PLoS one. 2016 Apr 4;11(4):e0152768-e0152768 e0152768 (2065482)

Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance
Tufano, Ralph P; Clayman, Gary; Heller, Keith S; Inabnet, William B; Kebebew, Electron; Shaha, Ashok; Steward, David L; Tuttle, R Michael. Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance. Thyroid. 2015 Jan ;25(1):15-27 (1450552)

Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS): Is There a Correct Answer?
Heller, Keith S. Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS): Is There a Correct Answer?. Thyroid. 2014 May ;24(5):787-788 (1004832)

Use of intraoperative parathyroid hormone assay
Heller, KS. Use of intraoperative parathyroid hormone assay IN: Minimally Invasive and Robotic Thyroid and Parathyroid Surgery. . p.125-130 (2169162)

Clinical and therapeutic implications of Sprouty2 feedback dysregulation in BRAF V600E-mutation-positive papillary thyroid cancer
Dultz, Linda A; Dhar, Shumon; Ogilvie, Jennifer B; Heller, Keith S; Bar-Sagi, Dafna; Patel, Kepal N. Clinical and therapeutic implications of Sprouty2 feedback dysregulation in BRAF V600E-mutation-positive papillary thyroid cancer. Surgery. 2013 Oct 2;154(6):1239-44; discussion 1244 (629882)